Physician profile
Eric Yeh
NPI 1255743878
$6,386.87
in general payments reported to CMS, 2019-2025
46 companies · $1,991 in 2025
The $1,991 reported for 2025 was more than what 95% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $226 · 2020: $295 · 2021: $304 · 2022: $929 · 2023: $1,030 · 2024: $1,613 · 2025: $1,991.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,633.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,632.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $947.04 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Abbvie INC. | $838.19 | 2021-2025 | Vraylar, Qulipta |
| Lilly USA, LLC | $822.67 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Astrazeneca Pharmaceuticals LP | $580.83 | 2019-2025 | Breztri, Airsupra, Farxiga |
| Pfizer INC. | $466.97 | 2020-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $240.78 | 2021-2025 | Jardiance |
| Bausch Health US, LLC | $193.69 | 2019-2024 | Aplenzin, Wellbutrin |
| Merck Sharp & Dohme LLC | $184.33 | 2019-2025 | Gardasil 9, Gardasil, Capvaxive |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $174.62 | 2021-2025 | Xifaxan |
| Exact Sciences Corporation | $146.44 | 2023-2025 | Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $143.72 | 2022-2025 | Trelegy Ellipta |
| Astellas Pharma US INC | $124.28 | 2019-2025 | Veozah |
| Takeda Pharmaceuticals U.S.A., INC. | $122.13 | 2019-2025 | Trintellix |
| Biohaven Pharmaceutical Holding Company LTD. | $111.53 | 2022 | |
| Abbott Laboratories | $105.62 | 2024-2025 | Freestyle Libre 3, Eterna |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Yeh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.